An anonymized hospital case: a patient who did well on tirzepatide stopped on her own, then went back to her previous dose. The clinician walks through what followed.
Recap by typeshit. Post by Facebook on Facebook.
Dr. Nadolsky, an obesity medicine doctor, gives his take on a recent GLP-1 warning in a short clip. Tap through to see which warning he means.
2:12
A short explainer on the experimental injection people call Reta, covering why it went viral and what is known so far about its safety.
A nationwide recall now covers a GLP-1 injectable. The full story names the affected medication and explains why it was pulled.
32:25
The channel walks through FDA inspection findings of mold at suppliers and what people taking GLP-1 medications should watch for.
10:37
PBS NewsHour reports on the growing research into whether GLP-1 medications could help with addiction to alcohol and other drugs.
1:04:07
Hasan Minhaj sits down with Yale obesity researcher Dr. Ania Jastreboff to dig into how GLP-1 drugs work and whether they live up to the attention.
Loading…